Annexon (NASDAQ:ANNX) highlighted progress across three programs targeting the classical complement pathway during a fireside ...

Lead antibody MB0109 targets C1q and uniquely inhibits both classical complement cascade and C1q-mediated macrophage/microglial activation — two key drivers of neuroinflammationMB0109 demonstrated ...

Creative Biolabs expands its research capabilities, offering diversified tools and services to support global biomedical innovation. SHIRLEY, NY, UNITED STATES, February 27, 2026 /EINPresswire.com/ — ...

-- The unmet need and current treatment landscape for GA -- The mechanism of disease and role of C1q -- Vonaprument, Annexon's neuroprotective C1q inhibitor with the potential to be the first targeted ...

Chennai: People whose immune systems mount an unusually aggressive early response to tuberculosis may be less likely to ...

Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 ...

A replay of the webcast will be archived on the Annexon website for 30 days following the presentation. Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted ...

Supa Nova by Chanté Timothy, a graphic novel about a young Black girl with a love for science, won the children’s fiction category and inaugural children’s choice prize ...

Sensory neurons detect internal and external cues in organs and send this information to the brain. Lung cancer exploits this pathway to lessen immune responses. Read the paper: Tumour–brain crosstalk ...

Jamestown occupies the southwestern section of New York, and it’s truly worth discovering. This community features a downtown ...

In the future, microexpression analysis could reshape how museums design marketing campaigns and craft exhibition narratives.

The Official Charts Company has launched a new chart focused on classical albums released in the last 12 months. Titled the Official Classical Chart, it showcases albums that are making an impact in ...